These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 10845871

  • 1. Cafestol increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis.
    Post SM, de Roos B, Vermeulen M, Afman L, Jong MC, Dahlmans VE, Havekes LM, Stellaard F, Katan MB, Princen HM.
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1551-6. PubMed ID: 10845871
    [Abstract] [Full Text] [Related]

  • 2. Dietary plant stanol esters reduce VLDL cholesterol secretion and bile saturation in apolipoprotein E*3-Leiden transgenic mice.
    Volger OL, van der Boom H, de Wit EC, van Duyvenvoorde W, Hornstra G, Plat J, Havekes LM, Mensink RP, Princen HM.
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1046-52. PubMed ID: 11397718
    [Abstract] [Full Text] [Related]

  • 3. Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background impairs very-low-density lipoprotein production.
    Post SM, Groenendijk M, Solaas K, Rensen PC, Princen HM.
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):768-74. PubMed ID: 14962946
    [Abstract] [Full Text] [Related]

  • 4. Cafestol, the cholesterol-raising factor in boiled coffee, suppresses bile acid synthesis by downregulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase in rat hepatocytes.
    Post SM, de Wit EC, Princen HM.
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3064-70. PubMed ID: 9409294
    [Abstract] [Full Text] [Related]

  • 5. Effects of dietary fish oil on serum lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3-Leiden transgenic mice.
    van Vlijmen BJ, Mensink RP, van 't Hof HB, Offermans RF, Hofker MH, Havekes LM.
    J Lipid Res; 1998 Jun; 39(6):1181-8. PubMed ID: 9643349
    [Abstract] [Full Text] [Related]

  • 6. Rosuvastatin reduces plasma lipids by inhibiting VLDL production and enhancing hepatobiliary lipid excretion in ApoE*3-leiden mice.
    Delsing DJ, Post SM, Groenendijk M, Solaas K, van der Boom H, van Duyvenvoorde W, de Wit EC, Bloks VW, Kuipers F, Havekes LM, Princen HM.
    J Cardiovasc Pharmacol; 2005 Jan; 45(1):53-60. PubMed ID: 15613980
    [Abstract] [Full Text] [Related]

  • 7. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors.
    Ricketts ML, Boekschoten MV, Kreeft AJ, Hooiveld GJ, Moen CJ, Müller M, Frants RR, Kasanmoentalib S, Post SM, Princen HM, Porter JG, Katan MB, Hofker MH, Moore DD.
    Mol Endocrinol; 2007 Jul; 21(7):1603-16. PubMed ID: 17456796
    [Abstract] [Full Text] [Related]

  • 8. Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.
    van Vlijmen BJ, van 't Hof HB, Mol MJ, van der Boom H, van der Zee A, Frants RR, Hofker MH, Havekes LM.
    J Clin Invest; 1996 Mar 01; 97(5):1184-92. PubMed ID: 8636429
    [Abstract] [Full Text] [Related]

  • 9. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH, Nguyen LB, Shefer S, Salen G, Batta AK, Frohlich JJ.
    Metabolism; 2001 Jun 01; 50(6):708-14. PubMed ID: 11398149
    [Abstract] [Full Text] [Related]

  • 10. Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background increases hepatic ABCA1 mRNA expression and HDL-cholesterol.
    Post SM, Groenendijk M, van der Hoogt CC, Fievet C, Luc G, Hoekstra M, Princen HM, Staels B, Rensen PC.
    Arterioscler Thromb Vasc Biol; 2006 Dec 01; 26(12):2724-30. PubMed ID: 17008588
    [Abstract] [Full Text] [Related]

  • 11. Characterization of very low density lipoproteins and intermediate density lipoproteins of normo- and hyperlipidemic apolipoprotein E-2 homozygotes.
    Schmitz G, Assmann G, Augustin J, Dirkes-Kersting A, Brennhaüsen B, Karoff C.
    J Lipid Res; 1985 Mar 01; 26(3):316-26. PubMed ID: 3989390
    [Abstract] [Full Text] [Related]

  • 12. The coffee diterpene cafestol increases plasma triacylglycerol by increasing the production rate of large VLDL apolipoprotein B in healthy normolipidemic subjects.
    de Roos B, Caslake MJ, Stalenhoef AF, Bedford D, Demacker PN, Katan MB, Packard CJ.
    Am J Clin Nutr; 2001 Jan 01; 73(1):45-52. PubMed ID: 11124749
    [Abstract] [Full Text] [Related]

  • 13. Increased production of apolipoprotein B-containing lipoproteins in the absence of hyperlipidemia in transgenic mice expressing cholesterol 7alpha-hydroxylase.
    Miyake JH, Doung XD, Strauss W, Moore GL, Castellani LW, Curtiss LK, Taylor JM, Davis RA.
    J Biol Chem; 2001 Jun 29; 276(26):23304-11. PubMed ID: 11323427
    [Abstract] [Full Text] [Related]

  • 14. Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression.
    van Dijk KW, van Vlijmen BJ, de Winther MP, van 't Hof B, van der Zee A, van der Boom H, Havekes LM, Hofker MH.
    Arterioscler Thromb Vasc Biol; 1999 Dec 29; 19(12):2945-51. PubMed ID: 10591674
    [Abstract] [Full Text] [Related]

  • 15. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC, Dahlmans VE, van Gorp PJ, van Dijk KW, Breuer ML, Hofker MH, Havekes LM.
    J Clin Invest; 1996 Nov 15; 98(10):2259-67. PubMed ID: 8941642
    [Abstract] [Full Text] [Related]

  • 16. Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice.
    Mensenkamp AR, van Luyn MJ, van Goor H, Bloks V, Apostel F, Greeve J, Hofker MH, Jong MC, van Vlijmen BJ, Havekes LM, Kuipers F.
    J Hepatol; 2000 Aug 15; 33(2):189-98. PubMed ID: 10952236
    [Abstract] [Full Text] [Related]

  • 17. Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice.
    Vasandani C, Kafrouni AI, Caronna A, Bashmakov Y, Gotthardt M, Horton JD, Spady DK.
    J Lipid Res; 2002 May 15; 43(5):772-84. PubMed ID: 11971949
    [Abstract] [Full Text] [Related]

  • 18. Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor.
    van Dijk KW, van Vlijmen BJ, van der Zee A, van't Hof B, van der Boom H, Kobayashi K, Chan L, Havekes LM, Hofker MH.
    Arterioscler Thromb Vasc Biol; 1998 Jan 15; 18(1):7-12. PubMed ID: 9445249
    [Abstract] [Full Text] [Related]

  • 19. Low-Density Lipoprotein Receptor-Dependent and Low-Density Lipoprotein Receptor-Independent Mechanisms of Cyclosporin A-Induced Dyslipidemia.
    Kockx M, Glaros E, Leung B, Ng TW, Berbée JF, Deswaerte V, Nawara D, Quinn C, Rye KA, Jessup W, Rensen PC, Meikle PJ, Kritharides L.
    Arterioscler Thromb Vasc Biol; 2016 Jul 15; 36(7):1338-49. PubMed ID: 27150391
    [Abstract] [Full Text] [Related]

  • 20. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.
    van Vlijmen BJ, Pearce NJ, Bergö M, Staels B, Yates JW, Gribble AD, Bond BC, Hofker MH, Havekes LM, Groot PH.
    Arzneimittelforschung; 1998 Apr 15; 48(4):396-402. PubMed ID: 9608883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.